The present invention relates to hydrazone compounds of Formula I:
and pharmaceutically acceptable salts and stereoisomers thereof, wherein R
1
, R
2
, R
3
, R
4
, L
1
, and L
2
are defined as set forth in the specification. The invention is also directed to the use of compounds of Formula I as inhibitors of TRPM5 protein.
本发明涉及式I的
腙化合物及其药用可接受的盐和立体异构体,其中R1、R2、R3、R4、L1和
L2的定义如规范中所述。本发明还涉及将式I的化合物用作TR
PM5蛋白质的
抑制剂。